Markets remain choppy, Auto surges
DSIJ Intelligence / 29 Nov 2016
The Indian markets have been witnessing choppy trades for two consecutive days. Today, after Auto stocks like Eicher Motors, Maruti and Bosch surged, the Nifty ended up by 15 points at 8142 and Sensex was up by 44 points at 26394. The indices ended the day higher by 0.17-0.19 per cent each.
The Indian markets have been witnessing choppy trades for two consecutive days. Today, after Auto stocks like Eicher Motors, Maruti and Bosch surged, the Nifty ended up by 15 points at 8142 and Sensex was up by 44 points at 26394. The indices ended the day higher by 0.17-0.19 per cent each.
The advance-decline ratio ended on the negative side. On the NSE, 32 shares closed in green, while 19 shares were in the red.
Majority of the sectoral indices closed on a negative note. Auto index led today’s rally up by 429 points. Consumer Durables, Mid-caps and Small-caps were outperformers of the day, up around 70-100 points. However Bankex, FMCG, Healthcare and IT closed in negative territory.
In the Asian markets, the Nikkei closed down by 49 points. While the Hang Seng index ended down by 93 points. The KOSPI and Shanghai Composite ended on a positive note.
European markets were also trading in mixed scenario.
Derivative Analysis
Nifty future is facing resistance above 8220/8250 mark, and a closing above these levels may see more positive up moves.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.